MARKET

SYK

SYK

Stryker Corp
NYSE

Real-time Quotes | Nasdaq Last Sale

231.70
-7.43
-3.11%
Opening 15:56 05/18 EDT
OPEN
237.26
PREV CLOSE
239.13
HIGH
237.37
LOW
231.20
VOLUME
814.20K
TURNOVER
27.92M
52 WEEK HIGH
281.16
52 WEEK LOW
224.02
MARKET CAP
87.62B
P/E (TTM)
43.98
1D
5D
1M
3M
1Y
5Y
What 7 Analyst Ratings Have To Say About Stryker
Analysts have provided the following ratings for Stryker (NYSE:SYK) within the last quarter:
Benzinga · 1d ago
Citigroup Adjusts Stryker's Price Target to $280 From $310, Reiterates Buy Rating
MT Newswires · 1d ago
Here's Why You Should Hold on to Stryker (SYK) Stock for Now
Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure weighs on it.
Zacks · 2d ago
AeroClean Announces Appointment of Timothy J. Scannell to Board of Directors
PALM BEACH GARDENS, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies (“AeroClean” or the “Company”) (Nasdaq: AERC), a pathogen elimination technology company harnessing patented UV-C LED technology with Pūrgo™ to significantly reduce and remov...
GlobeNewswire · 6d ago
Is Stryker Corporation's (NYSE:SYK) Shareholder Ownership Skewed Towards Insiders?
The big shareholder groups in Stryker Corporation ( NYSE:SYK ) have power over the company. Generally speaking, as a...
Simply Wall St. · 05/11 12:38
Stryker announces new Investor Relations leader
Kalamazoo, May 05, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that Jason Beach will be appointed Vice President, Investor Relations and report to Glenn Boehnlein, the company’s Chief Financial Officer, effective July 1, 2022. Preston Wells...
GlobeNewswire · 05/05 16:00
BRIEF-Stryker Announces Board Changes Following Annual Meeting Of Shareholders
reuters.com · 05/05 12:57
Stryker announces board changes following Annual Meeting of Shareholders
Kalamazoo, May 05, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced that on May 4, 2022, the company’s board of directors approved board leadership and committee assignment changes, naming Sherilyn S. McCoy to replace Allan C. Golston as Lead Indepen...
GlobeNewswire · 05/05 12:00
More
No Data
Learn about the latest financial forecast of SYK. Analyze the recent business situations of Stryker Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 29 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

34.48%Strong Buy
27.59%Buy
34.48%Hold
3.45%Under-perform
0.00%Sell
Analyst Price Target
The average SYK stock price target is 284.43 with a high estimate of 310.00 and a low estimate of 239.00.
High310.00
Average284.43
Low239.00
Current 231.70
EPS
Actual
Estimate
0.681.362.042.72
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 2.08K
Institutional Holdings: 311.73M
% Owned: 82.44%
Shares Outstanding: 378.15M
TypeInstitutionsShares
Increased
595
9.86M
New
179
1.53M
Decreased
515
9.02M
Sold Out
88
814.36K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-2.92%
Healthcare Equipment & Supplies
-2.55%
Key Executives
Chairman/President/Chief Executive Officer/Director
Kevin Lobo
Chief Financial Officer/Vice President
Glenn Boehnlein
Corporate Executive
Viju Menon
Corporate Executive
J. Andrew Pierce
Corporate Executive
Spencer Stiles
Chief Human Resource Officer/Vice President
M. Kathryn Fink
Chief Accounting Officer/Vice President
William Berry
Vice President/Director of Marketing
Yin Becker
Vice President
Robert Fletcher
Lead Director/Independent Director
Allan Golston
Independent Director
Mary Brainerd
Independent Director
Giovanni Caforio
Independent Director
Srikant Datar
Independent Director
Sherilyn McCoy
Independent Director
Andrew Silvernail
Independent Director
Lisa Skeete Tatum
Independent Director
Ronda Stryker
Independent Director
Rajeev Suri
No Data
No Data
About SYK
Stryker Corporation (Stryker) is a medical technology company. The Company offers products and services in Medical and Surgical, Neurotechnology, Orthopaedics, and Spine that help improve patient and hospital outcomes. Its products are sold in approximately 75 countries through Company-owned subsidiaries and branches, as well as, third-party dealers and distributors. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a range of medical specialties. Its business segments include MedSurg and Neurotechnology and Orthopaedics and Spine. Its subsidiaries include Alcott Indemnity Company, Arrinex, Inc., Berchtold Corporation, and BioMimetic Therapeutics, LLC.

Webull offers kinds of Stryker Corporation stock information, including NYSE:SYK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SYK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SYK stock methods without spending real money on the virtual paper trading platform.